Valuation for NewAmsterdam Pharma Company N.V. (id:6662 NAMS)
Financial Strength
| Name | Current | Vs Industry | Vs History |
|---|---|---|---|
| Trailing P/E | -11.86 |
|
|
| Forward P/E | -13.21 |
|
|
| Price to sales | 68.67 |
|
|
| Price to book | 6.07 |
|
|
| Enterprise to revenue | 56.10 |
|
|
| Enterprise to ebitda | -10.24 |
|
|